AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase

Circulation

Volumn 107, Issue 12, 2003, Pages 1632-1639

  Dechend, Ralf ^a   Viedt, Christiane ^b   Müller, Dominik N ^a   Ugele, Bernhard ^d   Brandes, Ralf P ^e   Wallukat, Gerd ^a   Park, Joon Keun ^c   Janke, Jurgen ^a   Barta, Peter ^a   Theuer, Jurgen ^a   Fiebeler, Anette ^c   Homuth, Volker ^a   Dietz, Rainer ^a   Haller, Hermann ^c   Kreuzer, Jörg ^b   Luft, Friedrich C ^a,f  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f NONE   (Germany)

Author keywords

Angiotensin; Antibodies; Cells; Oxygen; Pregnancy; Receptors, AT1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; AUTOANTIBODY; DIPHENYLIODONIUM SALT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TIRON; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER; TROPHOBLAST; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; DRUG POTENTIATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MOUSE; PREGNANCY;

ADULT; ANGIOTENSIN II; ANIMALS; AUTOANTIBODIES; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NF-KAPPA B; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; TROPHOBLASTS;

EID: 0037384016     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000058200.90059.B1     Document Type: Article

References (28)

1. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med. 1992:326:927-932.
2. Pascoal IF, Lindheimer MD, Brandt CN, et al. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. J Clin Invest. 1998;101:464-470.
3. Haller H, Hempel A, Homuth V, et al. Endothelial cell permeability and protein kinase C in preeclampsia. Lancet. 1998:351:945-949.
4. 1 receptor. J Clin Invest. 1999:1103:945-952.
5. Dechend R, Homuth V, Wallukat G, et al. AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 2000;101:2382-2387.
6. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999:222:222-235.
7. Walsh SW, Vaughan JE, Wang Y, et al. Placental isoprostane is significantly increased in preeclampsia. FASEB J. 2000;14:1289-1296.
8. Many A, Hubel CA, Fisher SJ. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol. 2000:156:321-331.
9. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;15:85:753-766.
10. Jackson SH, Gallin JI, Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med. 1995:182:751-758.
11. Ugele B, Regemann K. Differential increase of steroid sulfatase activity in XX and XY trophoblast cells from human term placenta with syncytia formation in vitro. Cytogenet Cell Genet. 2000;90:40-46.
12. Viedt C, Soto U, Krieger-Brauer HI, et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940-948.
13. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000;35:1270-1277.
14. Fleming I, Michaelis UR, Bredenkotter D, et al. Endothelium-derived hyperpolarizing factor synthase is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res. 2001;88:44-51.
15. Sikkema JM, van Rijn BB, Franx A, et al. Placental superoxide is increased in pre-eclampsia. Placenta. 2001;22:304-308.
16. De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol. 1975;123:164-174.
17. Barry-Lane PA, Patterson CM, van der Merwe M, et al. p47 phox is required for atherosclerotic lesion progression in ApoE -/- mice. J Clin Invest. 2001;108:1513-1522.
18. Hubel CA, Snaedal S, Ness RB, et al. Dyslipoproteinaemia in postmenopausal women with a history of eclampsia. Br J Obstet Gynaecol. 2000;107:776-784.
19. Griendling KK, Sorescu D, Masuko M, et al. NADPH oxidase role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
20. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med. 1997;22:269-285.
21. Redman CW, Sacks GP, Sargent IL. Preeclampsia, an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499-506.
22. McCracken S, Morris JM. Pregnancy is associated with a suppression of the NF-κB/IκBα activation pathway. Hypertens Pregnancy. 2000;19:1:4.
23. Myatt L, Rosenfield RB, Eis AL, et al. Nitrotyrosine residues in placenta: Evidence of peroxynitrite formation and action. Hypertension. 1996;28:488-493.
24. Hubel CA, Kagan VE, Kisin ER, et al. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: Implications for oxidative stress. Free Radic Biol Med. 1997;23:597-609.
25. Manes C. Human placental NAD(P)H oxidase: solubilization and properties. Placenta. 2001;22:58-63.
26. Morgan L, Baker P, Pipkin FB, et al. Pre-eclampsia and the angiotensinogen gene. Br J Obstet Gynaecol. 1995;102:489-490.
27. Petit A, Bullion G, Tence M, et al. Angiotensin II stimulates both inositol phosphate production and human placental lactogen release from human trophoblastic cells. J Clin Endocrinol Metab. 1989;69:280-286.
28. Roberts JM. Angiotensin-I receptor autoantibodies, a role in the pathogenesis of preeclampsia? Circulation. 2000;101:2335-2337.